Reference 9b
Antenatal screening for heritable thrombophilia
Antenatal screening for heritable thrombophilia
Reference No. | 9b |
| Reference Name | Antenatal screening for heritable thrombophilia |
| Advisory Panel | Professor Brendon Kearney (Chair and MSAC member) Professor Ian Fraser (MSAC member) Dr Ross Baker (Royal College of Pathologists nominee) Professor Robert Burrows (Haematological Society of Australia and Royal Australian and New Zealand College of Obstetrics and Gynaecology nominee) Professor James Isbister (co-opted member) Dr Ed Olszewski (Royal Australian College of General Practitioners nominee) Dr Beverley Rowbotham (Pathology Services Table Committee) Ms Rosi Trencher (Consumers' Health Forum of Australia nominee) |
| Date Received by MSAC Secretariat | August 2000 |
| Stage 1 - Eligibility | Eligible |
| Stage 2 - Assessment | Completed |
| Stage 3 - Formulation of Advice to the Minister | This assessment was considered by the MSAC at the 21 August 2002 meeting. The MSAC recommended that, on the strength of the evidence pertaining to antenatal screening for heritable thrombophilia, public funding should not be supportedfor systematic screening of all pregnant women. Since there is currently insufficient evidence pertaining to antenatal screening for heritable thrombophilia in high risk obstetric groups, the MSAC recommended that public funding should not be supported at this time for this procedure. However, this recommendation should be reviewed in two years time. |
| Stage 4 - Decision | Endorsed by the Minister for Health and Ageing 16 October 2002 |
| Stage 5 - Implementation |  |
Page currency, Latest update: 30 March, 2009
